CG Oncology, Inc. - Common stock (CGON) analyst actions
Rating and price-target actions on CGON in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the CGON overview →
1 measured CGON analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| CG Oncology Initiates Expanded Access Program for Cretostimogene Grenadenorepvec | Press release | +0.15% | +0.47% |
Keep exploring
More CGON: earnings → · SEC filings → · CGON overview →